| |
Article Title |
Author(s) |
Type |
Pages |
|
Expression of innate defense antimicrobial peptides in hidradenitis suppurativa
June 2012 (Vol. 66 | No. 6 | Pages 966-974)
|
Silke C. Hofmann,
Viola Saborowski,
Sylke Lange,
Winfried V. Kern,
Leena Bruckner-Tuderman,
Siegbert Rieg
et al.
|
Full-length article
|
966-974
|
|
Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension
April 2012 (Vol. 66 | No. 4 | Pages 626-633)
|
Jae Yoon Jung,
Jong Soo Hong,
Chang Ho Ahn,
Ji Young Yoon,
Hyuck Hoon Kwon,
Dae Hun Suh
et al.
|
Full-length article
|
626-633
|
|
Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)–a new autoinflammatory syndrome distinct from PAPA syndrome
March 2012 (Vol. 66 | No. 3 | Pages 409-415)
|
Markus Braun-Falco,
Oleksandr Kovnerystyy,
Peter Lohse,
Thomas Ruzicka
|
Full-length article
|
409-415
|
|
Acne scars: Classification and treatment
January 2012 (Vol. 66 | No. 1 | Pages 169-170)
|
Hayes Bordman Gladstone
|
Book review
|
169-170
|
|
Profound disturbances of sexual health in patients with acne inversa
19 December 2011
|
Agata Kurek,
Eva M.J. Peters,
Akewit Chanwangpong,
Robert Sabat,
Wolfram Sterry,
Sylke Schneider-Burrus
et al.
|
Full-length article
|
Article In Press
|
|
Acne severity grading: Determining essential clinical components and features using a Delphi consensus
31 October 2011
|
Jerry Tan,
Barat Wolfe,
Jonathan Weiss,
Linda Stein-Gold,
Joseph Bikowski,
James Del Rosso,
Guy F. Webster,
Anne Lucky,
Diane Thiboutot,
Jonathan Wilkin,
James Leyden,
Mary-Margaret Chren
et al.
|
Full-length article
|
Article In Press
|
|
Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension
April 2012 (Vol. 66 | No. 4 | Pages 626-633)
|
Jae Yoon Jung,
Jong Soo Hong,
Chang Ho Ahn,
Ji Young Yoon,
Hyuck Hoon Kwon,
Dae Hun Suh
et al.
|
Full-length article
|
626-633
|
|
Exacerbation of facial acne vulgaris after consuming pure chocolate
October 2011 (Vol. 65 | No. 4 | Pages e114-e115)
|
Samantha G. Block,
Whitney E. Valins,
Caroline V. Caperton,
Martha H. Viera,
Sadegh Amini,
Brian Berman
et al.
|
Short communication
|
e114-e115
|
|
Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne
October 2011 (Vol. 65 | No. 4 | Pages e117-e119)
|
Elizabeth M. Seidler,
Alexa B. Kimball
|
Short communication
|
e117-e119
|
|
Acne treatment and inflammatory bowel disease: What is the evidence?
September 2011 (Vol. 65 | No. 3 | Pages 650-654)
|
Ali Alikhan,
Gregory P. Henderson,
Lauren Becker,
Gabriel F. Sciallis
|
Short communication
|
650-654
|
|
Could higher doses of isotretinoin reduce the frequency of treatment failure in patients with acne?
August 2011 (Vol. 65 | No. 2 | Pages 422-423)
|
Jacquelyn Coloe,
Hongyan Du,
Dean S. Morrell
|
Short communication
|
422-423
|
|
Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)–a new autoinflammatory syndrome distinct from PAPA syndrome
March 2012 (Vol. 66 | No. 3 | Pages 409-415)
|
Markus Braun-Falco,
Oleksandr Kovnerystyy,
Peter Lohse,
Thomas Ruzicka
|
Full-length article
|
409-415
|
|
The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions
June 2011 (Vol. 64 | No. 6 | Pages 1085-1091)
|
Steven R. Feldman,
Jerry Tan,
Yves Poulin,
Thomas Dirschka,
Nabil Kerrouche,
Vasant Manna
et al.
|
Full-length article
|
1085-1091
|
|
A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris
April 2011 (Vol. 64 | No. 4 | Pages 793-795)
|
Brad A. Yentzer,
Amy L. Gosnell,
Adele R. Clark,
Daniel J. Pearce,
Rajesh Balkrishnan,
Fabian T. Camacho,
Trudye A. Young,
Julie M. Fountain,
Alan B. Fleischer,
Luz E. Colón,
Lori A. Johnson,
Norman Preston,
Steven R. Feldman
et al.
|
Short communication
|
793-795
|
